The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification
Authors:
Open Access
- 28 June 2017
- journal article
- research article
- Published by Georg Thieme Verlag KG in TH Open
- Vol. 01 (01) , e56-e65
Abstract
Background The IMPROVE score is a validated venous thromboembolism (VTE) assessment tool to risk stratify hospitalized, medically ill patients based on clinical variables. It was hypothesized that addition of D-dimer measurement to derive a new IMPROVEDD score would improve identification of at risk of VTE. Methods The association of the IMPROVE score and D-dimer ≥ 2 × the upper limit of normal (ULN) with the risk of symptomatic deep vein thrombosis, nonfatal pulmonary embolism, or VTE-related death was evaluated in 7,441 hospitalized, medically ill patients randomized in the APEX trial. Based on the Cox regression analysis, the IMPROVEDD score was derived by adding two points to the IMPROVE score if the D-dimer was ≥ 2 × ULN. Results Baseline D-dimer was independently associated with symptomatic VTE through 77 days (adjusted HR: 2.22 [95% CI: 1.38–1.58], p = 0.001). Incorporation of D-dimer into the IMPROVE score improved VTE risk discrimination (ΔAUC: 0.06 [95% CI: 0.02–0.09], p = 0.0006) and reclassification (continuous NRI: 0.34 [95% CI: 0.17–0.51], p = 0.001; categorical NRI: 0.13 [95% CI: 0.03–0.23], p = 0.0159). Patients with an IMPROVEDD score of ≥2 had a greater VTE risk compared with those with an IMPROVEDD score of 0 to 1 (HR: 2.73 [95% CI: 1.52–4.90], p = 0.0007). Conclusion Incorporation of D-dimer into the IMPROVE VTE risk assessment model further improves risk stratification in hospitalized, medically ill patients who received thromboprophylaxis. An IMPROVEDD score of ≥2 identifies hospitalized, medically ill patients with a heightened risk for VTE through 77 days.Keywords
This publication has 27 references indexed in Scilit:
- Biomarkers for prediction of venous thromboembolism in cancerBlood, 2013
- The global burden of unsafe medical care: analytic modelling of observational studiesBMJ Quality & Safety, 2013
- Prevention of VTE in Nonsurgical PatientsChest, 2012
- Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of PhysiciansAnnals of Internal Medicine, 2011
- Derivation and Validation of a Simple Model to Identify Venous Thromboembolism Risk in Medical PatientsThe American Journal of Medicine, 2011
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis, 2010
- Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary EmbolismCirculation, 2010
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006
- Electronic Alerts to Prevent Venous Thromboembolism among Hospitalized PatientsNew England Journal of Medicine, 2005